Table 2.
Osteogenesis potential between bone marrow mesenchymal stem cells and adipose-derived stem cells in animal model
Ref. | Animal model | Scaffold | Analytic methods | Outcome of osteogenic ability |
Hayashi et al[27] | Subcutaneous implantation in rat | Hydroxyapatite | Micro-CT | New bone volume BMSC (6.85 ± 1.89 mm3) > ASC (0.05 ± 0.05 mm3) |
Niemeyer et al[32] | 3-cm tibial defect in sheep | Collagen sponge | Radiographic and histologic analysis | BMSC > ASC BMSC = ASC + PRP No original data for bone volume |
Kang et al[23] | 1.5-cm radial bone defect in dog | Tricalcium phosphate | Radiographic, histological and histomorphometric analysis | New bone percentage: BMSC (33.56%) = ASC (33.9%) |
Stockmann et al[33] | 1-cm calvarial bone defect in pig | Bovine collagen type I | Microradiography, histomorphometric evaluation | BMSC = ASC No original data for bone volume |
Wen et al[34] | 5-mm calvarial defect in SD rat | Collagen gel | X-ray and histology | BMSC = ASC No original data for bone volume |
Zhang et al[21] | Subcutaneous pocket of nude mice | PCL/TCP | Micro-CT | New bone volume: BMSC (16.6 ± 3.0 mm3) > ASC (9.1 ± 1.1 mm3) |
BMSC: Bone marrow mesenchymal stem cell; ASC: Adipose-derived stem cell; PRP: Platelet rich plasma; PCL/TCP: Polycaprolactone/tricalcium phosphate; CT: Computed tomography.